Study validates disc diffusion method for Salmonella vaccine checks

A new Veterinary Sciences study takes aim at one of the more practical bottlenecks in poultry Salmonella control: telling a live vaccine strain from a real field isolate when a flock tests positive. The paper, “Reliable Differentiation of a Bivalent Live Salmonella Vaccine and Field Strains: Multi-Supplier Validation of a Disc Diffusion Method,” evaluates a culture-based disc diffusion approach across multiple suppliers, positioning it as a standardized way to distinguish vaccine-derived Salmonella Enteritidis and S. Typhimurium findings from true field strains. That may sound technical, but for poultry veterinarians and diagnostic labs, it's directly tied to how quickly they can interpret a positive result and what actions follow. (pmc.ncbi.nlm.nih.gov)

The background is longstanding. Live Salmonella vaccination in breeding and laying flocks has been an important part of reducing flock colonization and lowering downstream contamination risk in eggs and poultry meat. But because live vaccines can be reisolated after administration, surveillance systems need a dependable way to separate expected vaccine detections from evidence of infection. EU rules are explicit on this point: live Salmonella vaccines shouldn't be used in national control programs unless the manufacturer provides an appropriate bacteriological method to distinguish vaccine from wild-type strains. (eur-lex.europa.eu)

That regulatory requirement has shaped the market for differentiation tools. Earlier work has validated real-time PCR assays for distinguishing vaccine strains such as Salmovac SE/Gallivac SE and AviPro SALMONELLA VAC E from wild-type S. Enteritidis, with reported high inclusivity and exclusivity. Whole-genome sequencing approaches have also been developed to identify attenuation markers and separate vaccine-related isolates from field strains. More recently, researchers described an alternative chromogenic media approach for differentiating the Salmonella 441/014 vaccine strain from field strains. In other words, the new disc diffusion paper enters an active diagnostics space, but with a simpler, lower-tech method that may be easier for more routine laboratories to implement. (pubmed.ncbi.nlm.nih.gov)

The study's main contribution appears to be validation across multiple suppliers, which is important because reproducibility across labs is often the real hurdle for practical adoption. The paper focuses on a bivalent live vaccine covering the two serovars that matter most in poultry-associated human salmonellosis, Enteritidis and Typhimurium. The underlying concept isn't new, as antimicrobial susceptibility profiles have long been used to differentiate some live vaccine strains, but multi-supplier validation could strengthen confidence that the method is robust enough for routine use beyond a single manufacturer or reference setting. That lines up with official monitoring practice in Great Britain, where additional testing is required to distinguish certain vaccine strains from field strains, and validated differentiation tests are already part of national reference laboratory workflows. (assets.publishing.service.gov.uk)

Industry and technical commentary around this issue has been consistent even when not addressing this exact paper. Ceva's poultry vaccine education materials note that live vaccine strains can be identified in the host and that PCR and culture methods are commonly used for confirmation and differentiation. UK product information for poultry Salmonella vaccines likewise states that vaccine-field differentiation may rely on antibiogram methods or PCR. Taken together, that suggests the field isn't debating whether differentiation is necessary, but rather which method is most practical, scalable, and accepted by regulators and reference labs. (poultrycontent.ceva.com)

Why it matters: For veterinarians, especially those advising commercial poultry systems, the immediate value is decision support. A false assumption that a vaccine reisolate is a field strain can lead to costly follow-up sampling, movement restrictions, reputational damage, and potentially unnecessary flock-level interventions. A method based on standard disc diffusion could lower barriers for routine diagnostic use, particularly where PCR access is uneven or turnaround time matters. At the same time, interpretation will still need care, because antimicrobial resistance patterns in circulating Salmonella are changing. EFSA and ECDC's latest joint AMR report found increasing ciprofloxacin resistance trends in Salmonella from laying hens in some member states, a reminder that susceptibility-based tools need continued validation against the evolving field population. (pmc.ncbi.nlm.nih.gov)

The public health context keeps the issue relevant. In the EU/EEA, salmonellosis remained the second most commonly reported gastrointestinal infection in 2023, and eggs and egg products continue to be the highest-risk foods in Salmonella outbreaks. Fifteen member states and Northern Ireland met poultry prevalence reduction targets in 2023, showing that control programs are having an effect, but they depend on surveillance systems that can accurately interpret positive flock findings. Better differentiation tools support that system by helping labs and regulators respond proportionately. (ecdc.europa.eu)

What to watch: The next question is whether this disc diffusion method is incorporated into supplier guidance, national reference lab workflows, or product labeling, and whether it gains traction as a frontline option alongside PCR, chromogenic media, and WGS-based methods. Adoption will likely depend less on novelty than on inter-lab reproducibility, regulatory acceptance, and performance as field resistance patterns continue to shift. (pubmed.ncbi.nlm.nih.gov)